Divigel vs. Bijuve
See how Divigel and Bijuve compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Divigel is an estrogen-only gel, so women with a uterus typically need to add a separate progestogen, while Bijuve combines estradiol and progesterone in one capsule.
Both treat moderate to severe menopausal hot flashes, but Bijuve is approved only for women who still have a uterus.
Divigel offers four adjustable dose strengths for titration, while Bijuve comes in just two fixed combination doses.
Divigel vs. Bijuve Drug Summary
Divigel
Divigel is an estrogen hormone therapy applied as a topical gel once a day to treat moderate to severe hot flashes of menopause. It comes in four dose strengths, letting a clinician adjust the amount based on symptom response. Because it contains only estrogen, women with a uterus typically need to take a separate progestogen alongside it.
Bijuve
Bijuve is a combination hormone therapy capsule containing bioidentical estradiol and micronized progesterone, taken once a day by mouth to treat moderate to severe hot flashes of menopause. It is approved only for women who still have a uterus, since the progesterone component protects against endometrial overgrowth caused by estrogen. Bijuve comes in two fixed-dose strengths rather than a range of adjustable doses.
Divigel vs. Bijuve Side Effects
Divigel
Bijuve
Divigel vs. Bijuve Dosage
Divigel
Bijuve
| STAGE | DOSE | WHEN |
| Starting dose | 0.25 g once daily | At the start |
| Maximum dose | 1.0 g once daily | If needed |
| Dose changes | 3 increases | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 0.5 mg/100 mg once daily | At the start |
| Maximum dose | 1 mg/100 mg once daily | If needed |
| Dose changes | 1 increase | As tolerated |
Divigel
| STAGE | DOSE | WHEN |
| Starting dose | 0.25 g once daily | At the start |
| Maximum dose | 1.0 g once daily | If needed |
| Dose changes | 3 increases | As tolerated |
Bijuve
| STAGE | DOSE | WHEN |
| Starting dose | 0.5 mg/100 mg once daily | At the start |
| Maximum dose | 1 mg/100 mg once daily | If needed |
| Dose changes | 1 increase | As tolerated |
Divigel vs. Bijuve Indications
Divigel
Divigel is FDA-approved to treat moderate to severe hot flashes caused by menopause. It is also used off-label for vaginal dryness and atrophy, and for gender-affirming hormone therapy. It is not approved for preventing heart disease or dementia.
FDA-approved for moderate to severe menopausal hot flashes
Off-label use for vaginal dryness or atrophy
Off-label use in gender-affirming hormone therapy
Not approved for heart disease or dementia prevention
Bijuve
Bijuve is FDA-approved to treat moderate to severe hot flashes caused by menopause in women who still have a uterus. It pairs estrogen with progesterone in a single capsule so a separate progestogen is not needed. It is not approved for women without a uterus or for preventing heart disease, stroke, or dementia.
FDA-approved for moderate to severe menopausal hot flashes
Only approved for women with a uterus
Progesterone included, so no separate progestogen needed
Not approved for women without a uterus
Divigel vs. Bijuve Pros and Cons
Divigel
Divigel has the longest track record of any estrogen gel here, having been FDA-approved since 1975, and its four dose strengths allow for fine-tuned titration. As a topical gel, it avoids first-pass liver metabolism, which some studies suggest may lower clotting risk compared with oral estrogen. Because it lacks progesterone, it typically costs more overall once a companion progestogen prescription is added for women with a uterus.
Pros
Four dose strengths allow gradual, individualized titration
Topical application avoids first-pass liver metabolism
FDA-approved since 1975, longest history of the two
Can be paired with any progestogen, not locked to one formulation
Cons
Requires a separate progestogen for women with a uterus
Risk of transferring estrogen to others through skin contact
Daily gel application is less discreet than a capsule
Roughly $650 to $900 per month without insurance, pricier than Bijuve
Bijuve
Bijuve is the only FDA-approved capsule that combines bioidentical estradiol and micronized progesterone in a single daily dose, simplifying treatment for women with a uterus. Because progesterone is already built in, there is no need to coordinate a second prescription or separate dosing schedule. Its oral form and two fixed-dose strengths keep dosing simple but leave less room for gradual adjustment.
Pros
Combines estrogen and progesterone in one daily capsule
No separate progestogen prescription needed
No skin-contact transfer risk since it is swallowed
Roughly $257 to $351 per month without insurance, less than Divigel
Cons
Only two fixed-dose strengths, less room for fine titration
Not approved for women without a uterus
Oral form undergoes first-pass liver metabolism
Higher reported rate of breast tenderness, up to 10.4%
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.